Imatinib mesylate (STI571) inhibits growth of primitive malignant progenitors in chronic myelogenous leukemia through reversal of abnormally increased proliferation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples